Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters

Abstract Background Some people living with HIV-1 (PWH) do not reconstitute their CD4 + T cell counts despite complete inhibition of HIV-1 replication on antiretroviral therapy (AR); these are known as immunological nonresponders (INR). This is a retrospective analysis to estimate the prevalence of...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra Pinto-Cardoso, Monserrat Chávez-Torres, Mariana López-Filloy, Santiago Ávila-Ríos, Karla Romero-Mora, Amy Peralta-Prado
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-11318-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387799397007360
author Sandra Pinto-Cardoso
Monserrat Chávez-Torres
Mariana López-Filloy
Santiago Ávila-Ríos
Karla Romero-Mora
Amy Peralta-Prado
author_facet Sandra Pinto-Cardoso
Monserrat Chávez-Torres
Mariana López-Filloy
Santiago Ávila-Ríos
Karla Romero-Mora
Amy Peralta-Prado
author_sort Sandra Pinto-Cardoso
collection DOAJ
description Abstract Background Some people living with HIV-1 (PWH) do not reconstitute their CD4 + T cell counts despite complete inhibition of HIV-1 replication on antiretroviral therapy (AR); these are known as immunological nonresponders (INR). This is a retrospective analysis to estimate the prevalence of INR in a hospital-based cohort of PWH who initiated ART with severe immunodeficiency and/or opportunistic infections. We also explored mechanisms of poor immune recovery, with emphasis on the gut microbiome. Methods All PWH included in this study achieved virologic suppression (plasma viral load < 200 copies of HIV-1/mL) six months after ART initiation and remained virally suppressed thereafter. INR and immunological responders (IR) were defined according to the CD4 + T cell counts after 24-months on ART initiation (< 350 or ≥ 350 cells/µL, respectively). Both INR (n = 15) and IR (n = 15) were matched for nadir CD4 (< 200 cells/µL). Uninfected individuals at high-risk of HIV infection were also included (n = 40). We assessed indirect markers linked to HIV disease progression (markers of innate immune activation and enterocyte damage) and gut dysbiosis using cryopreserved plasma and stool samples using Enzyme-Linked immunosorbent Assay and 16S ribosomal DNA sequencing. Results The estimated prevalence of INR after 24-months on ART was 50%. Microbial translocation, gut epithelial damage and gut dysbiosis persisted in PWH on ART, yet were not different between INR and IR. After adjusting for multiple comparisons, we found that INR had lower alpha diversity (Shannon) and higher levels of sCD163 compared with PWoH (p = 0.013 and p = 0.017, respectively). No differentially-abundant genera were identified; differences in the gut microbiome were primarily driven by a Prevotella and Bacteroides gradient, which is linked to sexual practices (men who have sex with men, MSM). Indeed, in our cohort, most INR were non-MSM, while PWoH were all MSM. Conclusions In the Instituto Nacional de Enfermedades Respiratorias, a tertiary reference centre, a disproportionate number of individuals are diagnosed with HIV-1 with severe immunodeficiency and/or opportunistic infections; they represent a high-risk population for the INR phenotype. Our data on possible mechanisms of the INR phenotype linked to the gut microbiome yielded modest results, precluding any decisive conclusions. Interventions to boost the immune function in this at-risk population are warranted and deserving of further studies.
format Article
id doaj-art-b384d30fe79448cf9a4a56883eeca4e5
institution Kabale University
issn 1471-2334
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-b384d30fe79448cf9a4a56883eeca4e52025-08-20T03:42:30ZengBMCBMC Infectious Diseases1471-23342025-07-0125111310.1186/s12879-025-11318-2Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presentersSandra Pinto-Cardoso0Monserrat Chávez-Torres1Mariana López-Filloy2Santiago Ávila-Ríos3Karla Romero-Mora4Amy Peralta-Prado5Departamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasAbstract Background Some people living with HIV-1 (PWH) do not reconstitute their CD4 + T cell counts despite complete inhibition of HIV-1 replication on antiretroviral therapy (AR); these are known as immunological nonresponders (INR). This is a retrospective analysis to estimate the prevalence of INR in a hospital-based cohort of PWH who initiated ART with severe immunodeficiency and/or opportunistic infections. We also explored mechanisms of poor immune recovery, with emphasis on the gut microbiome. Methods All PWH included in this study achieved virologic suppression (plasma viral load < 200 copies of HIV-1/mL) six months after ART initiation and remained virally suppressed thereafter. INR and immunological responders (IR) were defined according to the CD4 + T cell counts after 24-months on ART initiation (< 350 or ≥ 350 cells/µL, respectively). Both INR (n = 15) and IR (n = 15) were matched for nadir CD4 (< 200 cells/µL). Uninfected individuals at high-risk of HIV infection were also included (n = 40). We assessed indirect markers linked to HIV disease progression (markers of innate immune activation and enterocyte damage) and gut dysbiosis using cryopreserved plasma and stool samples using Enzyme-Linked immunosorbent Assay and 16S ribosomal DNA sequencing. Results The estimated prevalence of INR after 24-months on ART was 50%. Microbial translocation, gut epithelial damage and gut dysbiosis persisted in PWH on ART, yet were not different between INR and IR. After adjusting for multiple comparisons, we found that INR had lower alpha diversity (Shannon) and higher levels of sCD163 compared with PWoH (p = 0.013 and p = 0.017, respectively). No differentially-abundant genera were identified; differences in the gut microbiome were primarily driven by a Prevotella and Bacteroides gradient, which is linked to sexual practices (men who have sex with men, MSM). Indeed, in our cohort, most INR were non-MSM, while PWoH were all MSM. Conclusions In the Instituto Nacional de Enfermedades Respiratorias, a tertiary reference centre, a disproportionate number of individuals are diagnosed with HIV-1 with severe immunodeficiency and/or opportunistic infections; they represent a high-risk population for the INR phenotype. Our data on possible mechanisms of the INR phenotype linked to the gut microbiome yielded modest results, precluding any decisive conclusions. Interventions to boost the immune function in this at-risk population are warranted and deserving of further studies.https://doi.org/10.1186/s12879-025-11318-2Immunological nonrespondersGut dysbiosisImmune recoveryMicrobial translocationImmune recoveryNadir CD4
spellingShingle Sandra Pinto-Cardoso
Monserrat Chávez-Torres
Mariana López-Filloy
Santiago Ávila-Ríos
Karla Romero-Mora
Amy Peralta-Prado
Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters
BMC Infectious Diseases
Immunological nonresponders
Gut dysbiosis
Immune recovery
Microbial translocation
Immune recovery
Nadir CD4
title Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters
title_full Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters
title_fullStr Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters
title_full_unstemmed Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters
title_short Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters
title_sort patterns of immune recovery in people living with hiv who initiated antiretroviral therapy as late presenters
topic Immunological nonresponders
Gut dysbiosis
Immune recovery
Microbial translocation
Immune recovery
Nadir CD4
url https://doi.org/10.1186/s12879-025-11318-2
work_keys_str_mv AT sandrapintocardoso patternsofimmunerecoveryinpeoplelivingwithhivwhoinitiatedantiretroviraltherapyaslatepresenters
AT monserratchaveztorres patternsofimmunerecoveryinpeoplelivingwithhivwhoinitiatedantiretroviraltherapyaslatepresenters
AT marianalopezfilloy patternsofimmunerecoveryinpeoplelivingwithhivwhoinitiatedantiretroviraltherapyaslatepresenters
AT santiagoavilarios patternsofimmunerecoveryinpeoplelivingwithhivwhoinitiatedantiretroviraltherapyaslatepresenters
AT karlaromeromora patternsofimmunerecoveryinpeoplelivingwithhivwhoinitiatedantiretroviraltherapyaslatepresenters
AT amyperaltaprado patternsofimmunerecoveryinpeoplelivingwithhivwhoinitiatedantiretroviraltherapyaslatepresenters